What's in Store for the Biotech Industry in 2015
As the biotech industry ramps up for the JPMorgan Healthcare conference, we continue our...
18:07
A Look at the Year That Was in Biotech
The year 2014 was one for the record books for the biotech industry. In part one of a two-part...
15:15
Why Privacy Concerns May Limit Big Data's Payoff
Two-thirds of Americans say they are willing to anonymously share their health information with...
13:40
Calculating the Cost of Drug Development and What It Means
The cost of drug development, a metric that underlies discussions ranging from investment in...
20:13
How New Funding Models Are Accelerating Drug Development
News last month of the Cystic Fibrosis Foundation’s $3.3 billion sale of royalty rights to...
18:12
Telemedicine Grows, but Reimbursement Remains an Obstacle
While many may think of telemedicine as an example of digital health technologies that will...
22:27
The Power of IBM’s Watson Is Coming to an App Near You
IBM’s Watson Group recently announced an investment in Pathway Genomics, part of a $100 million...
18:00
Brittany Maynard and the Debate over the Right to Die
Britanny Maynard, a 29-year-old woman with terminal brain cancer who chose to end her own life...
23:03
What's Driving the Booming Market for Orphan Drugs
The market for Orphan drugs is growing at more than twice the rate of other prescription...
18:28
Why Interoperability Is Much More than a Technology Problem
A new government report finds that healthcare providers in the United States are increasing their...
26:24
The Lean Startup Takes Hold in the Life Sciences
The National Science Foundation and the National Institutes of Health, concerned about seeing the...
22:54
Enlisting Monoclonal Antibodies to Combat Bacterial Resistance
There’s growing global concern about threat from antibiotic resistant pathogens. That’s leading...
21:16
The Forces Bringing Disruptive Change to Healthcare
Scientific breakthroughs, innovations in technology, and the changing use of data are among the...
21:13
How One Foundation is Getting the Biggest Bang for Its R&D Bucks
As pressure on government and corporate research budgets grow, organizations like the Multiple...
28:24
International Collaboration Seeks to Drive Breakthroughs in Progressive MS
There has been dramatic progress in the understanding and treatment of relapsing remitting...
23:36
Will Increased FDA Regulation of Diagnostics Speed or Slow Development of Personalized Medicine
The U.S. Food and Drug Administration is moving to expand its regulatory domain by adding...
26:45
Using Human Biology to Improve R&D
One problem with drug discovery and development is that answers about the way substances act in...
28:21
Reengineering Drug Discovery and Development
Drugmakers have employed new technologies to reduce the cost and time and it takes develop drugs...
21:02
The Year in Biotech So Far and What's Ahead
The biotech sector surged in the first half of the year despite volatile markets. M&A and...
21:35
Epirus Sees Opportunities for Biosimilars Outside U.S.
The regulatory pathway for biosimilars is still a work in progress at the U.S. Food and Drug...
17:33
Lo último de Negocios y sectores
兄弟で学生起業しマザーズ上場！
Episodio
363: Tomhetens dokument
Episodio
Premium
Plus